Patents by Inventor Manuel V. Sanchez-Felix

Manuel V. Sanchez-Felix has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPUTER-ASSISTED MEANS FOR ASSESSING LIFESTYLE RISK FACTORS
    Publication number: 20160210880
    Abstract: The present invention relates to methods of assessing disease susceptibility associated with dietary and lifestyle risk factors. The invention provides for analysis of alleles at loci of genes associated with lifestyle risk factors, and the disease susceptibility profile of an individual is determined by reference to datasets which further match the risk factor with lifestyle recommendations in order to produce a personalized lifestyle advice plan.
    Type: Application
    Filed: November 1, 2013
    Publication date: July 21, 2016
    Applicant: BODYSYNC, INC.
    Inventors: Rosalynn D. Gill, Christopher J. Martin, Manuel V. Sanchez-Felix
  • COMPUTER-ASSISTED MEANS FOR ASSESSING LIFESTYLE RISK FACTORS
    Publication number: 20120322036
    Abstract: The present invention relates to methods of assessing disease susceptibility associated with dietary and lifestyle risk factors. The invention provides for analysis of alleles at loci of genes associated with lifestyle risk factors, and the disease susceptibility profile of an individual is determined by reference to datasets which further match the risk factor with lifestyle recommendations in order to produce a personalized lifestyle advice plan.
    Type: Application
    Filed: August 21, 2012
    Publication date: December 20, 2012
    Inventors: Rosalynn D. Gill-Garrison, Christopher J. Martin, Manuel V. Sanchez-Felix
  • COMPUTER-ASSISTED MEANS FOR ASSESSING LIFESTYLE RISK FACTORS
    Publication number: 20110264375
    Abstract: The present invention relates to methods of assessing disease susceptibility associated with dietary and lifestyle risk factors. The invention provides for analysis of alleles at loci of genes associated with lifestyle risk factors, and the disease susceptibility profile of an individual is determined by reference to datasets which further match the risk factor with lifestyle recommendations in order to produce a personalized lifestyle advice plan.
    Type: Application
    Filed: March 28, 2011
    Publication date: October 27, 2011
    Inventors: Rosalynn D. Gill-Garrison, Christopher J. Martin, Manuel V. Sanchez-Felix
  • Computer-assisted means for assessing lifestyle risk factors
    Publication number: 20100286923
    Abstract: The present invention relates to methods of assessing disease susceptibility associated with dietary and lifestyle risk factors. The invention provides for analysis of alleles at loci of genes associated with lifestyle risk factors, and the disease susceptibility profile of an individual is determined by reference to datasets which further match the risk factor with lifestyle recommendations in order to produce a personalized lifestyle advice plan.
    Type: Application
    Filed: November 30, 2009
    Publication date: November 11, 2010
    Inventors: Rosalynn D. Gill-Garrison, Christopher J. Martin, Manuel V. Sanchez-Felix
  • 2-methyl-thieno-benzodiazepine formulation
    Patent number: 7303764
    Abstract: The invention provides a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation of olanzapine or olanzapine pamoate or solvates thereof. The invention further provides novel olanzapine pamoate salts or solvates thereof.
    Type: Grant
    Filed: July 3, 2003
    Date of Patent: December 4, 2007
    Assignee: Eli Lilly and Company
    Inventors: Douglas J. Allen, Kurt D. Dekemper, Thomas H. Ferguson, Stuart J. Garvin, Linda C. Murray, Norman D. Brooks, Charles A. Bunnell, Snehlata S. Mascarenhas, Sharon L. Shinkle, Barry A. Hendriksen, David E. Tupper, Manuel V. Sanchez-Felix
  • Computer-assisted means for assessing lifestyle risk factors
    Patent number: 7054758
    Abstract: The present invention relates to methods of assessing disease susceptibility associated with dietary and lifestyle risk factors. The invention provides for analysis of alleles at loci of genes associated with lifestyle risk factors, and the disease susceptibility profile of an individual is determined by reference to datasets which further match the risk factor with lifestyle recommendations in order to produce a personalized lifestyle advice plan.
    Type: Grant
    Filed: January 30, 2001
    Date of Patent: May 30, 2006
    Assignee: Sciona Limited
    Inventors: Rosalynn D. Gill-Garrison, Christopher J. Martin, Manuel V. Sanchez-Felix
  • 2-methyl-thieno-benzodiazepine formulation
    Publication number: 20040097489
    Abstract: The invention provides a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation of olanzapine or olanzapine pamoate or solvates thereof. The invention further provides novel olanzapine pamoate salts or solvates thereof.
    Type: Application
    Filed: July 3, 2003
    Publication date: May 20, 2004
    Inventors: Douglas J. Allen, Kurt D. Dekemper, Thomas H. Ferguson, Stuart J. Garvin, Linda C. Murray, Norman D. Brooks, Charles A. Bunnell, Snehlata S. Mascarenhas, Sharon L. Shinkle, Barry A. Hendriksen, David E. Tupper, Manuel V. Sanchez-Felix
  • 2-methyl-thieno-benzodiazepine formulation
    Patent number: 6617321
    Abstract: The invention provides a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation or olanzapine or olanzapine pamoate or solvates thereof. The invention further provides novel olanzapine pamoate salts or solvates thereof.
    Type: Grant
    Filed: May 1, 2002
    Date of Patent: September 9, 2003
    Assignee: Eli Lilly and Company
    Inventors: Douglas J. Allen, Kurt D. Dekemper, Thomas H. Ferguson, Stuart J. Garvin, Linda C. Murray, Norman D. Brooks, Charles A. Bunnell, Snehlata S. Mascarenhas, Sharon L. Shinkle, Barry A. Hendriksen, David E. Tupper, Manuel V. Sanchez-Felix
  • 2-methyl-thieno-benzodiazepine formulation
    Publication number: 20030027816
    Abstract: The invention provides a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation of olanzapine or olanzapine pamoate or solvates thereof. The invention further provides novel olanzapine pamoate salts or solvates thereof.
    Type: Application
    Filed: May 1, 2002
    Publication date: February 6, 2003
    Inventors: Douglas J. Allen, Kurt D. Dekemper, Thomas H. Ferguson, Stuart J. Garvin, Linda C. Murray, Norman D. Brooks, Charles A. Bunnell, Snehlata S. Mascarenhas, Sharon L. Shinkle, Barry A. Hendriksen, David E. Tupper, Manuel V. Sanchez-Felix
  • Computer-assisted means for assessing lifestyle risk factors
    Publication number: 20030023387
    Abstract: The present invention relates to methods of assessing disease susceptibility associated with dietary and lifestyle risk factors. The invention provides for analysis of alleles at loci of genes associated with lifestyle risk factors, and the disease susceptibility profile of an individual is determined by reference to datasets which further match the risk factor with lifestyle recommendations in order to produce a personalized lifestyle advice plan.
    Type: Application
    Filed: January 30, 2001
    Publication date: January 30, 2003
    Inventors: Rosalynn D. Gill-Garrison, Christopher J. Martin, Manuel V. Sanchez-Felix